We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

0 hedge funds and large institutions have $294K invested in Quoin Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

60% less capital invested

Capital invested by funds: $741K → $294K (-$447K)

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$423K
2
APA
American Portfolios Advisors
New York
-$4.76K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$84K -$423K -1 Closed
Citadel Advisors
2
Citadel Advisors
Florida
$62K – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$47K – – –
Morgan Stanley
4
Morgan Stanley
New York
$32K – – –
SIGI
5
Susquehanna International Group (Ireland)
Ireland
$25K – – –
RJFSA
6
Raymond James Financial Services Advisors
Florida
$24K – – –
Citigroup
7
Citigroup
New York
$20K – – –
APA
8
American Portfolios Advisors
New York
– -$4.76K – –

QNRX Hedge Fund Activity: Q4 2018 in Review

0 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q4 2018, worth a combined $294K — down 60% from $741K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of QNRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $423K sold.

  • 0 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q4 2018, down from 1 in Q3 2018.
  • Funds reported $294K of Quoin Pharmaceuticals stock for Q4 2018, down 60% quarter-over-quarter.
  • 0 funds opened new Quoin Pharmaceuticals positions in Q4 2018 and 1 closed out, a net change of -1 holder.
  • The largest Quoin Pharmaceuticals seller in Q4 2018 was Sabby Management, an estimated $423K sold.

Based on aggregated 13F filings for Q4 2018.